HighVista Strategies’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-5,212
| Closed | -$333K | – | 172 |
|
2025
Q1 | $333K | Buy |
+5,212
| New | +$333K | 0.13% | 136 |
|
2024
Q3 | – | Sell |
-2,364
| Closed | -$374K | – | 165 |
|
2024
Q2 | $374K | Buy |
+2,364
| New | +$374K | 0.14% | 123 |
|
2023
Q4 | – | Sell |
-4,781
| Closed | -$580K | – | 145 |
|
2023
Q3 | $580K | Sell |
4,781
-224
| -4% | -$27.2K | 0.27% | 89 |
|
2023
Q2 | $573K | Sell |
5,005
-2,708
| -35% | -$310K | 0.26% | 114 |
|
2023
Q1 | $1.06M | Hold |
7,713
| – | – | 0.87% | 33 |
|
2022
Q4 | $999K | Sell |
7,713
-296
| -4% | -$38.4K | 0.59% | 44 |
|
2022
Q3 | $885K | Sell |
8,009
-1,572
| -16% | -$174K | 0.51% | 48 |
|
2022
Q2 | $718K | Sell |
9,581
-1,729
| -15% | -$130K | 0.43% | 54 |
|
2022
Q1 | $884K | Buy |
+11,310
| New | +$884K | 0.56% | 46 |
|
2021
Q1 | – | Sell |
-5,667
| Closed | -$966K | – | 139 |
|
2020
Q4 | $966K | Buy |
+5,667
| New | +$966K | 0.62% | 29 |
|
2020
Q3 | – | Sell |
-2,570
| Closed | -$412K | – | 130 |
|
2020
Q2 | $412K | Buy |
+2,570
| New | +$412K | 0.34% | 58 |
|